Trial Outcomes & Findings for Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty (NCT NCT03457116)
NCT ID: NCT03457116
Last Updated: 2021-11-23
Results Overview
Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)
COMPLETED
PHASE4
70 participants
Day 0
2021-11-23
Participant Flow
Participant milestones
| Measure |
NSAIDS
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
|---|---|---|
|
Overall Study
STARTED
|
41
|
29
|
|
Overall Study
COMPLETED
|
41
|
29
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty
Baseline characteristics by cohort
| Measure |
NSAIDS
n=41 Participants
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
Total
n=70 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32 years
n=5 Participants
|
32 years
n=7 Participants
|
32 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
22 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
41 Participants
n=5 Participants
|
29 Participants
n=7 Participants
|
70 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day 0Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)
Outcome measures
| Measure |
NSAIDS
n=41 Participants
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
|---|---|---|
|
Average Pain Score
|
2.54 score on a scale
Standard Deviation 1.57
|
3.14 score on a scale
Standard Deviation 1.75
|
PRIMARY outcome
Timeframe: Day 1Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)
Outcome measures
| Measure |
NSAIDS
n=41 Participants
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
|---|---|---|
|
Average Pain Score
|
1.84 score on a scale
Standard Deviation 1.29
|
2.46 score on a scale
Standard Deviation 1.90
|
PRIMARY outcome
Timeframe: Day 7Pain scores are reported via Post-Operative Pain Management Survey. On a scale of 1-10, participants indicate how much pain they were in on their pain regiment. The higher the score, the worse the pain (1 = no pain, 10 = worst pain possible)
Outcome measures
| Measure |
NSAIDS
n=41 Participants
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
|---|---|---|
|
Average Pain Score
|
3.29 score on a scale
Standard Deviation 2.14
|
3.14 score on a scale
Standard Deviation 2.12
|
PRIMARY outcome
Timeframe: Day 7Self-reported via Post-Operative Pain Management Survey
Outcome measures
| Measure |
NSAIDS
n=41 Participants
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
n=29 Participants
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
|---|---|---|
|
Average Post-Operative Day (POD) of Medication Cessation
|
4.73 days
Standard Deviation 1.57
|
4.28 days
Standard Deviation 2.23
|
SECONDARY outcome
Timeframe: Day 7Population: This outcome measure is only applicable to NSAIDS
Outcome measures
| Measure |
NSAIDS
n=41 Participants
400mg of Ibuprofen
NSAID: Ibuprofen 400mg for post-operative pain
|
Opiates
Norco (hydrocodone 5mg- acetaminophen 325mg)
Norco: 20 tablets of Hydrocodone 5mg-Acetaminophen 325mg (Norco)
|
|---|---|---|
|
Number of Participants in NSAIDs Group Who Were Upgraded to Opiates Due to High Levels of Pain
|
5 Participants
|
—
|
Adverse Events
NSAIDS
Opiates
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place